Antiviral AgentsMutagensVirus ReplicationAcyclovirOrganophosphonatesRimantadineDrug Resistance, ViralAmantadineTrifluridineOseltamivirViral Plaque AssayInterferonsNucleosidesInfluenza, HumanRibavirinZanamivirGanciclovirCell LineHepacivirusCytosineVero CellsVirus DiseasesFoscarnetProdrugsInterferon-alphaHIV-1Cercopithecus aethiopsCytomegalovirusIdoxuridineOrganophosphorus CompoundsRNA, ViralZalcitabineSimplexvirusVirusesRibonucleosidesAdenineAnti-HIV AgentsInfluenza A Virus, H1N1 Subtype2-AminopurineInfluenza B virusInfluenza A virusOrthomyxoviridaePost-Exposure ProphylaxisHepatitis B virusHerpes SimplexZidovudineLamivudineViral ProteinsReverse Transcriptase InhibitorsInhibitory Concentration 50PyransMolecular Sequence DataCytomegalovirus InfectionsViral Nonstructural ProteinsHepatitis B, ChronicHepatitis C, ChronicHIVHerpesvirus 1, HumanCells, CulturedInterferon Type IArabinonucleotidesVidarabine PhosphateDrug Therapy, CombinationDNA, ViralVirus InternalizationArabinofuranosyluracilDrug Evaluation, PreclinicalStructure-Activity RelationshipVidarabineCytopathogenic Effect, ViralHerpesviridaeHepatitis CDrug DesignNeuraminidaseViral LoadHerpesvirus 2, HumanEnterovirus A, HumanEye Infections, ViralAmino Acid SequenceInterferon-betaHepatitis BDideoxynucleosidesIsoxazolesMyxovirus Resistance ProteinsInfluenza A Virus, H3N2 SubtypeHerpes ZosterRepliconInfluenza A Virus, H5N1 SubtypeMutationInfluenza VaccinesProtease InhibitorsModels, MolecularGuanineHeLa CellsMolecular StructureVesicular stomatitis Indiana virusVirus ActivationVaccinia virusHerpesvirus 3, HumanHerpesviridae Infections